Parathyroid Hormone for the Treatment of Humerus Fractures

• Status: Unknown status
• Trial end date: 2013-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Hypothesis:

The investigators want to study whether parathyroid hormone improves healing of humerus after a fracture. The investigators will assess healing of the humerus with Constant score.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hvidovre University Hospital
• Collaborator: Takeda
• Treatments: Hormones; Parathyroid Hormone

Criteria

Inclusion Criteria:

• proximal humeral fracture eligible for conservative treatment.

• able to understand the protocol

• signs an informed consent

Exclusion Criteria:

• liver disease

• kidney disease

• severe osteoporosis

• malignant disease

• bone metabolic disease

• oral treatment with bisphosphonates during the last 3 months.

• treatment with Denosumab during the last 6 months.

• intravenous treatment with bisphosphonates during the last 12 months.